{Reference Type}: Journal Article
{Title}: Management of recurrent implantation failure: British Fertility Society policy and practice guideline.
{Author}: Mascarenhas M;Jeve Y;Polanski L;Sharpe A;Yasmin E;Bhandari HM; ;
{Journal}: Hum Fertil (Camb)
{Volume}: 25
{Issue}: 5
{Year}: Dec 2022
{Factor}: 2.186
{DOI}: 10.1080/14647273.2021.1905886
{Abstract}: Recurrent implantation failure (RIF) is defined as the absence of a positive pregnancy test after three consecutive transfers of good quality embryos. There remains significant variation in clinical practice in the management of RIF. This British Fertility Society (BFS) Policy and Practice guideline analyses the evidence for investigations and therapies that are employed in RIF and provides recommendations for clinical practice and for further research. Evidence for investigations of sperm and egg quality, uterine and adnexal factors, immunological factors and thrombophilia, endocrine conditions and genetic factors and for associated therapies have been evaluated. This guideline has been devised to assist reproductive medicine specialists and patients in making shared decisions concerning management of RIF. Finally, suggestions for research towards improving understanding and management of RIF have also been provided.